Last Updated on June 22, 2023

Current Pharmaceutical Design- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Bentham Science Publishers B.V.

Abbreviation: Curr. Pharm. Des.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

2.99

SJR

 0.580

h-Index

 176

Rank

 8897

Important Details

Title Current Pharmaceutical Design
Standard Abbreviation Curr. Pharm. Des.
Type of Publication Journal
Discipline Drug Discovery (Q2); Pharmacology (Q2)
Impact Score 2.99
SCImago Journal Rank (SJR) 0.580
h-index 176
Overall Rank 8897
Publisher Name Bentham Science Publishers B.V.
Publication Country United Arab Emirates
International Standard Serial Number (ISSN) 13816128, 18734286
Coverage and History 1995-2022
Best Quartile Q2
Total Citations Received
(Last 3 Year)
4651

About Current Pharmaceutical Design


Current Pharmaceutical Design is a journal published by Bentham Science Publishers B.V.. This journal covers the area[s] related to Drug Discovery, Pharmacology, etc. The coverage history of this journal is as follows: 1995-2022. The rank of this journal is 8897. This journal's impact score, h-index, and SJR are 2.99, 176, and 0.580, respectively. The ISSN of this journal is/are as follows: 13816128, 18734286.

The best quartile of Current Pharmaceutical Design is Q2. This journal has received a total of 4651 citations during the last three years (Preceding 2022).


Current Pharmaceutical Design Impact Score 2022-2023


The latest impact score (IS) of the Current Pharmaceutical Design is 2.99. It is computed in the year 2023 as per its definition and based on Scopus data. 2.99

It is increased by a factor of around 0, and the percentage change is 0% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Current Pharmaceutical Design Impact Score 2023


Impact Score 2022 of Current Pharmaceutical Design is 2.99. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Current Pharmaceutical Design. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.99
2021 2.99
2020 2.68
2019 2.18
2018 2.46
2017 2.65
2016 2.73
2015 3.19
2014 3.50

Current Pharmaceutical Design h-index


  Table Setting

The h-index of Current Pharmaceutical Design is 176. By definition of the h-index, this journal has at least 176 published articles with more than 176 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Current Pharmaceutical Design ISSN


The International Standard Serial Number (ISSN) of Current Pharmaceutical Design is/are as follows: 13816128, 18734286.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Current Pharmaceutical Design Ranking and SCImago Journal Rank (SJR)


The Current Pharmaceutical Design is ranked 8897 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.580.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Current Pharmaceutical Design Publisher


Table Setting

The publisher of Current Pharmaceutical Design is Bentham Science Publishers B.V.. The publishing house of this journal is located in the United Arab Emirates. Its coverage history is as follows: 1995-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Current Pharmaceutical Design is Curr. Pharm. Des.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Curr. Pharm. Des.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Current Pharmaceutical Design


If your area of research or discipline is related to Drug Discovery, Pharmacology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Current Pharmaceutical Design?

The latest impact score of Current Pharmaceutical Design is 2.99. It is computed in the year 2023.


What is the h-index of Current Pharmaceutical Design?

The latest h-index of Current Pharmaceutical Design is 176. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Current Pharmaceutical Design?

The latest SCImago Journal Rank (SJR) of Current Pharmaceutical Design is 0.580. It is calculated in the year 2023.


What is the ranking of Current Pharmaceutical Design?

The latest ranking of Current Pharmaceutical Design is 8897. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Current Pharmaceutical Design?

Current Pharmaceutical Design is published by Bentham Science Publishers B.V.. The publication country of this journal is United Arab Emirates.


What is the abbreviation of Current Pharmaceutical Design?

This standard abbreviation of Current Pharmaceutical Design is Curr. Pharm. Des..


Is "Current Pharmaceutical Design" a Journal, Conference or Book Series?

Current Pharmaceutical Design is a journal published by Bentham Science Publishers B.V..


What is the scope of Current Pharmaceutical Design?

The scope of Current Pharmaceutical Design is as follows:

  • Drug Discovery
  • Pharmacology

For detailed scope of Current Pharmaceutical Design, check the official website of this journal.


What is the ISSN of Current Pharmaceutical Design?

The International Standard Serial Number (ISSN) of Current Pharmaceutical Design is/are as follows: 13816128, 18734286.


What is the best quartile for Current Pharmaceutical Design?

The best quartile for Current Pharmaceutical Design is Q2.


What is the coverage history of Current Pharmaceutical Design?

The coverage history of Current Pharmaceutical Design is as follows 1995-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Qualitative Research Journal SAGE Publications Ltd 2108 86 3.97
Journal of Business Finance and Accounting Journal Wiley-Blackwell Publishing Ltd 3221 84 3.68
World Englishes Journal Wiley-Blackwell 4960 60 1.97
Howard Journal of Communications Journal Taylor and Francis Ltd. 9564 36 1.66
Palaeontographica Abteilung B: Palaeophytologie Book Series E. Schweizerbart'sche Verlagsbuchhandlung 15138 16 2.20
Korean Journal of Applied Microbiology and Biotechnology Journal Korean Society for Applied Microbiology 22033 0 0.00
Population Review Journal Sociological Demography Press 17841 13 0.73
Exploration Geophysics Journal Taylor and Francis Ltd. 16383 48 1.17
Canadian Journal of Mathematics Journal Canadian Mathematical Society 3905 43 0.79
Expert Review of Clinical Pharmacology Journal Taylor and Francis Ltd. 5241 53 4.10

Check complete list




Current Pharmaceutical Design Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 2.99
2021 2.99
2020 2.68
2019 2.18
2018 2.46
2017 2.65
2016 2.73
2015 3.19
2014 3.50



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

Expert Opinion on Therapeutic Targets
Taylor and Francis Ltd. | United Kingdom

Nucleic Acid Therapeutics
Mary Ann Liebert Inc. | United States

Drug Discovery Today
Elsevier Ltd. | United Kingdom

Current Opinion in Systems Biology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Acta Pharmaceutica Sinica B
Elsevier BV | Netherlands

See All